These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10795421)

  • 1. Wizards and gatekeepers at the roadside?
    Sci Justice; 2000; 40(1):1. PubMed ID: 10795421
    [No Abstract]   [Full Text] [Related]  

  • 2. Roadside drug testing would not be much of a deterrent.
    Winstock AR
    BMJ; 2012 Mar; 344():e2133. PubMed ID: 22438373
    [No Abstract]   [Full Text] [Related]  

  • 3. What to do when drivers test positive for methadone in roadside drug tests? The Spanish Experience.
    Herrera-Gómez F; Alvarez FJ
    Adicciones; 2019 Sep; 31(4):324-326. PubMed ID: 31018008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of breath-alcohol screening test results with venous blood alcohol concentration in suspected drunken drivers.
    Kriikku P; Wilhelm L; Jenckel S; Rintatalo J; Hurme J; Kramer J; Jones AW; Ojanperä I
    Forensic Sci Int; 2014 Jun; 239():57-61. PubMed ID: 24747668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canada's new drug-impaired driving law: the need to consider other approaches.
    Solomon R; Chamberlain E
    Traffic Inj Prev; 2014; 15(7):685-93. PubMed ID: 24380375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Victorian legislative framework for the random testing drivers at the roadside for the presence of illicit drugs: an evaluation of the characteristics of drivers detected from 2004 to 2006.
    Boorman M; Owens K
    Traffic Inj Prev; 2009 Mar; 10(1):16-22. PubMed ID: 19214873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood from a line - Is it admissible?
    Beaumont G
    J Forensic Leg Med; 2007 Jan; 14(1):46-8. PubMed ID: 17046309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drugs, drugged driving and per se laws.
    Voas RB; DuPont RL; Shea CL; Talpins SK
    Inj Prev; 2013 Jun; 19(3):218-21. PubMed ID: 23024170
    [No Abstract]   [Full Text] [Related]  

  • 9. Methamphetamine and driving.
    Lemos NP
    Sci Justice; 2009 Dec; 49(4):247-9. PubMed ID: 20120602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances.
    Jones AW
    Traffic Inj Prev; 2005 Dec; 6(4):317-22. PubMed ID: 16266940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a roadside impairment test device using alcohol.
    Dixon PR; Clark T; Tiplady B
    Accid Anal Prev; 2009 May; 41(3):412-8. PubMed ID: 19393786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing cannabis-impaired driving: is there sufficient evidence for drug testing of drivers?
    Hall W; Homel R
    Addiction; 2007 Dec; 102(12):1918-9. PubMed ID: 18031427
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of the Queensland 2007-2012 roadside drug testing program: The prevalence of three illicit drugs.
    Davey J; Armstrong K; Martin P
    Accid Anal Prev; 2014 Apr; 65():11-7. PubMed ID: 24389088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roadside drug testing: unanswered questions and future challenges.
    Lenné MG
    Drug Alcohol Rev; 2007 Mar; 26(2):107-8. PubMed ID: 17364844
    [No Abstract]   [Full Text] [Related]  

  • 16. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Drug Evaluation and Classification program: a critical review of the evidence.
    Beirness DJ; LeCavalier J; Singhal D
    Traffic Inj Prev; 2007 Dec; 8(4):368-76. PubMed ID: 17994490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a more parsimonious approach to drug recognition expert evaluations.
    Porath-Waller AJ; Beirness DJ; Beasley EE
    Traffic Inj Prev; 2009 Dec; 10(6):513-8. PubMed ID: 19916120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
    Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
    Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of evidence is not the same as evidence for absence!
    Bramness JG; Skurtveit S; Gustavsen I; Mørland J
    Addiction; 2008 Mar; 103(3):513-4. PubMed ID: 18269374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.